Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.20%
SPX
+0.14%
IXIC
+0.27%
FTSE
+0.64%
N225
+0.19%
AXJO
+0.54%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

No Cashu articles
Mereo Biopharma Group Plc currently has no Cashu-related articles

Key Stats

Market Cap
255.99M
Dividend Yield
0.00%
P/E Ratio
-19.86
EPS
-0.35
Revenue
-
Avg. Volume
991.19K

About

What does MREO do?
Mereo BioPharma Group Plc develops therapeutics for oncology and rare diseases, focusing on setrusumab for osteogenesis imperfecta and alvelestat for alpha-1-antitrypsin deficiency. The company also has oncology candidates and partnered programs like Navicixizumab.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
United Kingdom
Website
http://www.mereobiopharma.com
Stocks
Health Care
mreo
Mereo Biopharma Group Plc
MREO
+0.10 (+6.52%)
1.715
USD
At close at Jul 14, 20:44 UTC
Summary
News
Signals
Benchmarks
Financials